Logo image of RPAI

Retail Properties of America (RPAI) Stock Fundamental Analysis

NYSE:RPAI - New York Stock Exchange, Inc. -

13.15  -0.43 (-3.17%)

After market: 13.29 +0.14 (+1.06%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RPAI. RPAI was compared to 130 industry peers in the Diversified REITs industry. RPAI may be in some trouble as it scores bad on both profitability and health. RPAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RPAI had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.54%
ROE 1.24%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 21.41%
PM (TTM) 4.32%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

RPAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

RPAI has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.00% over the past year.
Measured over the past years, RPAI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.13% on average per year.
Looking at the last year, RPAI shows a decrease in Revenue. The Revenue has decreased by -0.19% in the last year.
RPAI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.57% yearly.
EPS 1Y (TTM)125%
EPS 3Y-66.24%
EPS 5Y-25.13%
EPS Q2Q%275%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y-7.2%
Revenue growth 5Y-6.57%
Sales Q2Q%25.24%

3.2 Future

RPAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.75% yearly.
The Revenue is expected to grow by 3.10% on average over the next years.
EPS Next Y53%
EPS Next 2Y49.8%
EPS Next 3Y49.11%
EPS Next 5Y47.75%
Revenue Next Year6.32%
Revenue Next 2Y4.32%
Revenue Next 3Y3.97%
Revenue Next 5Y3.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RPAI Yearly Revenue VS EstimatesRPAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
RPAI Yearly EPS VS EstimatesRPAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 146.11, which means the current valuation is very expensive for RPAI.
RPAI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.22.
Based on the Price/Forward Earnings ratio of 146.50, the valuation of RPAI can be described as expensive.
The average S&P500 Price/Forward Earnings ratio is at 20.86. RPAI is valued rather expensively when compared to this.
Industry RankSector Rank
PE 146.11
Fwd PE 146.5
RPAI Price Earnings VS Forward Price EarningsRPAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.43
RPAI Per share dataRPAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RPAI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as RPAI's earnings are expected to grow with 49.11% in the coming years.
PEG (NY)2.76
PEG (5Y)N/A
EPS Next 2Y49.8%
EPS Next 3Y49.11%

More info and screens

3

5. Dividend

5.1 Amount

RPAI has a Yearly Dividend Yield of 2.28%.
RPAI's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

The dividend of RPAI decreases each year by -12.38%.
RPAI has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-12.38%
Div Incr YearsN/A
Div Non Decr YearsN/A
RPAI Yearly Dividends per shareRPAI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6

5.3 Sustainability

54.41% of the earnings are spent on dividend by RPAI. This is a bit on the high side, but may be sustainable.
DP54.41%
EPS Next 2Y49.8%
EPS Next 3Y49.11%
RPAI Dividend Payout.RPAI Dividend Payout, showing the Payout Ratio.RPAI Dividend Payout.PayoutRetained Earnings

More info and screens

Retail Properties of America

NYSE:RPAI (10/21/2021, 8:23:34 PM)

After market: 13.29 +0.14 (+1.06%)

13.15

-0.43 (-3.17%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change0%
Market Cap2.82B
Analysts50
Price Target13.06 (-0.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend0.3
Dividend Growth(5Y)-12.38%
DP54.41%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 146.11
Fwd PE 146.5
P/S 6.21
P/FCF N/A
P/OCF N/A
P/B 1.78
P/tB N/A
EV/EBITDA 16.43
EPS(TTM)0.09
EY0.68%
EPS(NY)0.09
Fwd EY0.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.12
BVpS7.37
TBVpSN/A
PEG (NY)2.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.54%
ROE 1.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 21.41%
PM (TTM) 4.32%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125%
EPS 3Y-66.24%
EPS 5Y-25.13%
EPS Q2Q%275%
EPS Next Y53%
EPS Next 2Y49.8%
EPS Next 3Y49.11%
EPS Next 5Y47.75%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y-7.2%
Revenue growth 5Y-6.57%
Sales Q2Q%25.24%
Revenue Next Year6.32%
Revenue Next 2Y4.32%
Revenue Next 3Y3.97%
Revenue Next 5Y3.1%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A